MedTrace Logo

Study to Identify the Reduction of Exacerbations Resulting in Hospital Admission in Patients With COPD.

NCT05440188 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2023-12-06

No results posted yet for this study

Summary

identification of the reduction of exacerbations resulting in hospital admission in COPD patients after the use of the Breath Detect telemedicine platform.

Conditions

  • COPD Exacerbation

Interventions

DIAGNOSTIC_TEST

Breath Detect Platform

Use of the Breath Detect platform for respiratory health monitoring.

Sponsors & Collaborators

  • Universidad Autonoma de Madrid

    lead OTHER

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2023-08-23
Completion
2023-10-23

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05440188 on ClinicalTrials.gov